Biosimilars/Follow-on-Biologics Market - Global Outlook and Forecast 2023-2027

Report ID: 830324 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Biosimilars/follow-on-biologics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Biosimilars/follow-on-biologics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Biosimilars/follow-on-biologics Overall Market Size
    2.1 Global Biosimilars/follow-on-biologics Market Size: 2021 VS 2027
    2.2 Global Biosimilars/follow-on-biologics Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Biosimilars/follow-on-biologics Players in Global Market
    3.2 Top Global Biosimilars/follow-on-biologics Companies Ranked by Revenue
    3.3 Global Biosimilars/follow-on-biologics Revenue by Companies
    3.4 Top 3 and Top 5 Biosimilars/follow-on-biologics Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Biosimilars/follow-on-biologics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Biosimilars/follow-on-biologics Players in Global Market
        3.6.1 List of Global Tier 1 Biosimilars/follow-on-biologics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Biosimilars/follow-on-biologics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Biosimilars/follow-on-biologics Market Size Markets, 2021 & 2027
        4.1.2 Human growth hormone
        4.1.3 Erythropoietin
        4.1.4 Monoclonal antibodies
        4.1.5 Insulin
        4.1.6 Interferon
        4.1.7 Granulocyte-Colony Stimulating Factor
        4.1.8 Others
    4.2 By Type - Global Biosimilars/follow-on-biologics Revenue & Forecasts
        4.2.1 By Type - Global Biosimilars/follow-on-biologics Revenue, 2016-2021
        4.2.2 By Type - Global Biosimilars/follow-on-biologics Revenue, 2022-2027
        4.2.3 By Type - Global Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Biosimilars/follow-on-biologics Market Size, 2021 & 2027
        5.1.2 Blood Disorders
        5.1.3 Oncology Diseases
        5.1.4 Chronic and Autoimmune Diseases
        5.1.5 Growth Hormone Deficiencies
        5.1.6 Others
    5.2 By Application - Global Biosimilars/follow-on-biologics Revenue & Forecasts
        5.2.1 By Application - Global Biosimilars/follow-on-biologics Revenue, 2016-2021
        5.2.2 By Application - Global Biosimilars/follow-on-biologics Revenue, 2022-2027
        5.2.3 By Application - Global Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Biosimilars/follow-on-biologics Market Size, 2021 & 2027
    6.2 By Region - Global Biosimilars/follow-on-biologics Revenue & Forecasts
        6.2.1 By Region - Global Biosimilars/follow-on-biologics Revenue, 2016-2021
        6.2.2 By Region - Global Biosimilars/follow-on-biologics Revenue, 2022-2027
        6.2.3 By Region - Global Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Biosimilars/follow-on-biologics Revenue, 2016-2027
        6.3.2 US Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.3.3 Canada Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.3.4 Mexico Biosimilars/follow-on-biologics Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Biosimilars/follow-on-biologics Revenue, 2016-2027
        6.4.2 Germany Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.4.3 France Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.4.4 U.K. Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.4.5 Italy Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.4.6 Russia Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.4.7 Nordic Countries Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.4.8 Benelux Biosimilars/follow-on-biologics Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Biosimilars/follow-on-biologics Revenue, 2016-2027
        6.5.2 China Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.5.3 Japan Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.5.4 South Korea Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.5.5 Southeast Asia Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.5.6 India Biosimilars/follow-on-biologics Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Biosimilars/follow-on-biologics Revenue, 2016-2027
        6.6.2 Brazil Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.6.3 Argentina Biosimilars/follow-on-biologics Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue, 2016-2027
        6.7.2 Turkey Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.7.3 Israel Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.7.4 Saudi Arabia Biosimilars/follow-on-biologics Market Size, 2016-2027
        6.7.5 UAE Biosimilars/follow-on-biologics Market Size, 2016-2027
7 Players Profiles
    7.1 Novartis (Sandoz)
        7.1.1 Novartis (Sandoz) Corporate Summary
        7.1.2 Novartis (Sandoz) Business Overview
        7.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Major Product Offerings
        7.1.4 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue in Global (2016-2021)
        7.1.5 Novartis (Sandoz) Key News
    7.2 Synthon Pharmaceuticals
        7.2.1 Synthon Pharmaceuticals Corporate Summary
        7.2.2 Synthon Pharmaceuticals Business Overview
        7.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Major Product Offerings
        7.2.4 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue in Global (2016-2021)
        7.2.5 Synthon Pharmaceuticals Key News
    7.3 Teva Pharmaceutical Industries
        7.3.1 Teva Pharmaceutical Industries Corporate Summary
        7.3.2 Teva Pharmaceutical Industries Business Overview
        7.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Major Product Offerings
        7.3.4 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue in Global (2016-2021)
        7.3.5 Teva Pharmaceutical Industries Key News
    7.4 LG Life Sciences
        7.4.1 LG Life Sciences Corporate Summary
        7.4.2 LG Life Sciences Business Overview
        7.4.3 LG Life Sciences Biosimilars/follow-on-biologics Major Product Offerings
        7.4.4 LG Life Sciences Biosimilars/follow-on-biologics Revenue in Global (2016-2021)
        7.4.5 LG Life Sciences Key News
    7.5 Celltrion Biocon
        7.5.1 Celltrion Biocon Corporate Summary
        7.5.2 Celltrion Biocon Business Overview
        7.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Major Product Offerings
        7.5.4 Celltrion Biocon Biosimilars/follow-on-biologics Revenue in Global (2016-2021)
        7.5.5 Celltrion Biocon Key News
    7.6 Hospira
        7.6.1 Hospira Corporate Summary
        7.6.2 Hospira Business Overview
        7.6.3 Hospira Biosimilars/follow-on-biologics Major Product Offerings
        7.6.4 Hospira Biosimilars/follow-on-biologics Revenue in Global (2016-2021)
        7.6.5 Hospira Key News
    7.7 Merck Serono (Merck)
        7.7.1 Merck Serono (Merck) Corporate Summary
        7.7.2 Merck Serono (Merck) Business Overview
        7.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Major Product Offerings
        7.4.4 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue in Global (2016-2021)
        7.7.5 Merck Serono (Merck) Key News
    7.8 Biogen idec
        7.8.1 Biogen idec Corporate Summary
        7.8.2 Biogen idec Business Overview
        7.8.3 Biogen idec Biosimilars/follow-on-biologics Major Product Offerings
        7.8.4 Biogen idec Biosimilars/follow-on-biologics Revenue in Global (2016-2021)
        7.8.5 Biogen idec Key News
    7.9 Genentech (Roche)
        7.9.1 Genentech (Roche) Corporate Summary
        7.9.2 Genentech (Roche) Business Overview
        7.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Major Product Offerings
        7.9.4 Genentech (Roche) Biosimilars/follow-on-biologics Revenue in Global (2016-2021)
        7.9.5 Genentech (Roche) Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Biosimilars/follow-on-biologics Market Opportunities & Trends in Global Market
    Table 2. Biosimilars/follow-on-biologics Market Drivers in Global Market
    Table 3. Biosimilars/follow-on-biologics Market Restraints in Global Market
    Table 4. Key Players of Biosimilars/follow-on-biologics in Global Market
    Table 5. Top Biosimilars/follow-on-biologics Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Biosimilars/follow-on-biologics Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Biosimilars/follow-on-biologics Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Biosimilars/follow-on-biologics Product Type
    Table 9. List of Global Tier 1 Biosimilars/follow-on-biologics Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Biosimilars/follow-on-biologics Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Biosimilars/follow-on-biologics Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Biosimilars/follow-on-biologics Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2022-2027
    Table 30. Novartis (Sandoz) Corporate Summary
    Table 31. Novartis (Sandoz) Biosimilars/follow-on-biologics Product Offerings
    Table 32. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue (US$, Mn), (2016-2021)
    Table 33. Synthon Pharmaceuticals Corporate Summary
    Table 34. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Offerings
    Table 35. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue (US$, Mn), (2016-2021)
    Table 36. Teva Pharmaceutical Industries Corporate Summary
    Table 37. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Offerings
    Table 38. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue (US$, Mn), (2016-2021)
    Table 39. LG Life Sciences Corporate Summary
    Table 40. LG Life Sciences Biosimilars/follow-on-biologics Product Offerings
    Table 41. LG Life Sciences Biosimilars/follow-on-biologics Revenue (US$, Mn), (2016-2021)
    Table 42. Celltrion Biocon Corporate Summary
    Table 43. Celltrion Biocon Biosimilars/follow-on-biologics Product Offerings
    Table 44. Celltrion Biocon Biosimilars/follow-on-biologics Revenue (US$, Mn), (2016-2021)
    Table 45. Hospira Corporate Summary
    Table 46. Hospira Biosimilars/follow-on-biologics Product Offerings
    Table 47. Hospira Biosimilars/follow-on-biologics Revenue (US$, Mn), (2016-2021)
    Table 48. Merck Serono (Merck) Corporate Summary
    Table 49. Merck Serono (Merck) Biosimilars/follow-on-biologics Product Offerings
    Table 50. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue (US$, Mn), (2016-2021)
    Table 51. Biogen idec Corporate Summary
    Table 52. Biogen idec Biosimilars/follow-on-biologics Product Offerings
    Table 53. Biogen idec Biosimilars/follow-on-biologics Revenue (US$, Mn), (2016-2021)
    Table 54. Genentech (Roche) Corporate Summary
    Table 55. Genentech (Roche) Biosimilars/follow-on-biologics Product Offerings
    Table 56. Genentech (Roche) Biosimilars/follow-on-biologics Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Biosimilars/follow-on-biologics Segment by Type
    Figure 2. Biosimilars/follow-on-biologics Segment by Application
    Figure 3. Global Biosimilars/follow-on-biologics Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Biosimilars/follow-on-biologics Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Biosimilars/follow-on-biologics Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Biosimilars/follow-on-biologics Revenue in 2020
    Figure 8. By Type - Global Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
    Figure 12. US Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
    Figure 16. Germany Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 17. France Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
    Figure 24. China Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 28. India Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
    Figure 30. Brazil Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue Market Share, 2016-2027
    Figure 33. Turkey Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2016-2027
    Figure 37. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. LG Life Sciences Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Celltrion Biocon Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Hospira Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. Biogen idec Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 45. Genentech (Roche) Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Biosimilars/Follow-on-Biologics Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biosimilars/Follow-on-Biologics Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biosimilars/Follow-on-Biologics Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports